Photo by Jbud77 on seedfinder.eu | CC BY-NC-SA Project SPECTRE: novel study on vaporized CBD and THC effects interaction in humans Commonly distributed on SQDC store shelves, cannabis products composed of various ∆9-tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations are making waves in Quebec. Based on the most recent Enquête québécoise sur le cannabis 2022 (2023), 11,8% of surveyed users that…
READ MOREWhat do people with psychosis want in cannabis harm reduction interventions? Up to 60% of young people with psychosis uses cannabis, which is associated with significantly poorer clinical and psychosocial outcomes. While existing cannabis interventions typically focus on abstinence or reduction, effective interventions remain scarce, often hindered by low engagement or retention rates. There is a growing demand for harm…
READ MOREIntroducing the ASCME* project Methamphetamine use has increased considerably worldwide in recent years (1). Canada, like the rest of the world, is confronted with this problematic growth (2). Methamphetamine use is associated with significant long-term morbidity and mortality, including psychiatric, physical and social complications, placing a heavy burden on the healthcare system (3). At present, there are no pharmaceutical drugs…
READ MORECHUM Research Center (CRCHUM)
900 St-Denis St., 4th & 5th floor,
Montreal (QC) H2X0A9
Phone: 514-890-8000 #30933
Email: labo.jutras.aswad@gmail.com
To contact the media relations team: andree-anne.toussaint.chum@ssss.gouv.qc.ca
Myths and realities of a clinical research study
*People wishing to participate in one of the studies or who have questions about them can contact the lab. People who wish to obtain addiction and/or mental health care or services can contact the addiction rehabilitation center or the psychosocial center in their region. They can also call emergency services if their condition requires it.